Newsletters

  • All
  • AMR Action Fund
  • Can you help?
  • CARB-X
  • CDC
  • FDA
  • Government Action
  • Jobs
  • Meetings
  • PK & PK-PD
  • Push/Pull
  • R&D Insight
  • RFPs
  • Something Different
  • Summaries
  • Wellcome Trust
  • WHO
  • Wonkish
All
  • All
  • AMR Action Fund
  • Can you help?
  • CARB-X
  • CDC
  • FDA
  • Government Action
  • Jobs
  • Meetings
  • PK & PK-PD
  • Push/Pull
  • R&D Insight
  • RFPs
  • Something Different
  • Summaries
  • Wellcome Trust
  • WHO
  • Wonkish
R&D Insight

Colistin is nephrotoxic / Antibiotic stewardship knowledge gaps / Fire extinguisher video

Dear All, To start your week, we have three tidbits for consideration. First, results from a trial entitled “Colistin versus meropenem ...
Read More >
R&D Insight

UK NHS Antibiotic Subscription Pilot: Game (almost) on!

Dear All, 3 Apr 2020 update: Significant additional details on the pilot were shared via a 29 Mar 2020 webinar ...
Read More >
FDAMeetings

18-19 Nov 2019 FDA-IDSA-NIH-Pew Workshop: Enhancing Antibacterial Trials in the US

Dear All, Long note alert: Set aside at least 30 minutes for this one … there’s a lot of important ...
Read More >
R&D InsightSummaries

Looking forward: The global pre-clinical antibacterial pipeline / How will we care for these precious jewels?

​Dear All, Long note alert! There are two deep and deeply connected topics to share today. Refresh your coffee and ...
Read More >
CDCR&D Insight

CDC’s 2019 update to its 2013 Antibiotic Resistance Report — A superb update!

Dear All, I’ve been hearing rumors about this report for a couple of weeks but now it’s out! The US ...
Read More >
R&D InsightWHO

CMS foreshadows reimbursement actions/ GARDP’s 5-year plan / WHO toolkit / UK AMR Review update

Dear All, Today’s topics all share the theme of Less Talk, More Action! Here we go… First up … news from the ...
Read More >
R&D Insight

Ways to talk about AMR / Powerful new insights into messages that do (and do NOT) work

Dear All: Verbatim comments from interviews with 12,000 people in Germany, India, Japan, Kenya, the UK, the USA and Thailand: ...
Read More >
R&D Insight

BARDA seeks to support a VC-like mechanism for Medical Countermeasure (MCM) innovation / Your chance to provide input!

Dear All, BARDA is (yet again!) pushing the envelope with novel ways to support innovation. Their DRIVe group has just released an ...
Read More >
CARB-XJobs

CARB-X at work! New funding round, new job opportunities

Dear All, Two things on a Friday afternoon: First,CARB-X Funding Round 4 will be open from 12-19 Nov 2019 for Expressions ...
Read More >
FDAMeetings

Save the date: 18-19 Nov 2019 FDA-IDSA-NIAID-Pew-sponsored workshop: “How can we improve antibacterial development?”

Dear All, Please mark your calendar now to be in the Washington, DC area on 18-19 Nov 2019 for a 2-day ...
Read More >
MeetingsR&D Insight

ASM-ESCMID (3-6 Sep 2019, Boston): Post-meeting notes and annotated presentations

Dear All, Apologies for the delay, but I’ve held off on this note until the majority of the presentations from ...
Read More >
R&D InsightSomething Different

Superb podcast series: From “We can treat your cancer but you’ll die of infection” to “Tracking AMR by analyzing airplane toilet waste”

Dear All, I previously wrote (link) about the first of Jason Gale‘s 4-part podcast series on AMR. The whole series is ...
Read More >
CDCR&D Insight

DHHS Secretary Alex Azar, CDC, and Dame Sally Davies: An event to celebrate AMR fighters around the globe

Dear All, If you’re going to be in New York City on 23 Sep for the UN General Assembly, you ...
Read More >
R&D InsightSomething Different

Superb podcasts x 2: “Your cancer will be controlled, but you may die of infection” and “Pharma needs to be (and stay) engaged”

Dear All, Clear analyses by our colleagues in the science-focused media are invaluable ways to educate both ourselves and others: ...
Read More >
CARB-XR&D Insight

Clostridioides difficile / CARB-X Year 3 Annual Report / White House OSTP seeks input on the US Bioeconomy

Dear All, Committing serial email this afternoon… First, the note I just sent on FMT for Clostridium difficile (link) prompted comments that the ...
Read More >
FDAR&D Insight

FDA public hearing on Fecal Microbiota Transplantation (FMT) to Treat Clostridium difficile

Dear All, On 4 Nov 2019 at their White Oak Campus, FDA will hold a public hearing from 9a-4p on ...
Read More >
R&D Insight

Novo REPAIR’s 2019 US-Canada funding round is open; Global AMR R&D hub seeks your input

Dear All, Two time-limited opportunities have been announced in the past few days. First, the Novo REPAIR Impact Fund has opened ...
Read More >
R&D Insight

Alan Carr’s Sep 2019 Antibacterial-Antifungal Update; Pews’ updated pipeline review

Dear All, First, Alan Carr’s Sep 2019 Antibiotic and Antifungal Update (link) is, as usual, required reading (see also this prior blog). Key ...
Read More >
R&D InsightWHO

WHO wants your input on its draft TPPs for needed antibacterial agents

Dear All, WHO has developed a set of draft TPPs (target product profiles) for needed new antibiotics. As part of ...
Read More >
CDCR&D Insight

India bans food ag use of colistin / CDC updates report on US use of antibiotics

Dear All, Two mid-week notes: First (and huge!), India’s Ministry of Health issued a notification last week prohibiting the “manufacture, sale and ...
Read More >
Scroll to Top